Ajuste direto para aquisição de O4 - OCTREOTIDO [0,1 MG/1ML; F/AMP] para suprir necessidades na área da saúde

ID 11307028 · Portal BASE
Price
Base Price
€390,746 .00
Effective Price
€14,774 .00 -96.2%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Lisboa, Lisboa
Bidder Count
1
Winner
PHARMIS BIOFARMACÊUTICA LDA
NIF 502595442
Company
Competition
1 bidder recorded
PHARMIS BIOFARMACÊUTICA LDA
NIF 502595442
Dates
Publication
26 Mar 2025
Celebration
10 Mar 2025
Contracting Entity
Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE
NIF 506361616
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 70 · HIGH RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
26 Mar 2025
Signing Date
10 Mar 2025
Days Late
16
Rule
A2/A3 late publication: 16 days after signing (threshold: 10)
Detected 2026-03-06
A6 · Low Competition
A6_LOW_COMPETITION
MEDIUM
Rule
a6_single_bidder
Bidder count
1
Detected 2026-04-17
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
390746.0
Total effective price
14774.0
Ratio
0.0378
Direction
reduction
Rule
A9 price reduction: ratio 0.0378 outside [0.5, 1.5]
Detected 2026-03-06